ABOUT
THE INITIATIVE AND THE COMMITTEE
Welcome to the
Department of Health and Human Services (HHS) Regulatory Reform
Web-Site. On June 8, 2001, HHS
Secretary Thompson announced a Department-wide initiative to
reduce regulatory burdens in health care and respond faster to the
concerns of health care providers, state and local governments,
and individual Americans who are affected by HHS rules. As
part of this initiative, the Department established the Secretary's
Advisory Committee on Regulatory Reform to provide findings in
and recommendations regarding potential regulatory changes that
would enable HHS programs to reduce burdens and costs associated
with Departmental regulations, while at the same time maintaining
or enhancing effectiveness, efficiency, impact, and accessibility.
The Advisory Committee was established in accordance with the Federal
Advisory Committee Act.
The Advisory Committee
was the principal means for seeking broad-based guidance for the
Department's efforts to streamline regulatory requirements.
During 2002, the Advisory Committee advised and made
recommendations for changes that would have beneficial changes in
four broad areas: health care delivery, health systems operations,
biomedical and health research, and the development of
pharmaceuticals and other products.
The Committee
reviewed
changes identified through regional hearings, written comments
from the public and consultation with HHS staff. To learn
more about committee activities, click
here.
A steering committee
was established to provide guidance and direction to an
ongoing review of HHS regulations. The steering committee
members were Bobby Jindal (Chair), Assistant Secretary for Planning
and Evaluation, Alex Azar, General Counsel, William Hubbard, Food
and Drug Administration Senior Associate Commissioner for Policy,
Planning and Legislation, and Tom Scully, Centers for Medicare and
Medicaid Services Administrator.
|